CureVac - Stock Price History | CVAC

Historical daily share price chart and data for CureVac since 2021 adjusted for splits. The latest closing stock price for CureVac as of September 27, 2021 is 56.19.
  • The all-time high CureVac stock closing price was 136.27 on December 09, 2020.
  • The CureVac 52-week high stock price is 151.80, which is 170.2% above the current share price.
  • The CureVac 52-week low stock price is 46.12, which is 17.9% below the current share price.
  • The average CureVac stock price for the last 52 weeks is 83.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CureVac Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 69.4879 55.9000 136.2700 43.8000 81.0700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.503B $0.056B
CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29